2019 logo_150x35_jpg.jpg
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
July 17, 2023 08:45 ET | Novan, Inc.
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15...
2019 logo_150x35_jpg.jpg
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
June 05, 2023 09:00 ET | Novan, Inc.
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of...
2019 logo_150x35_jpg.jpg
Novan Focuses Strategic Direction and Announces Restructuring
May 31, 2023 16:05 ET | Novan, Inc.
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business...
2019 logo_150x35_jpg.jpg
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
May 08, 2023 09:05 ET | Novan, Inc.
DURHAM, N.C., May 08, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its first quarter 2023 financial results on Monday, May...
2019 logo_150x35_jpg.jpg
Novan Announces Closing of $6.0 Million Registered Direct Offering
March 16, 2023 16:15 ET | Novan, Inc.
DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the closing of the issuance and sale in the Company’s previously announced...
2019 logo_150x35_jpg.jpg
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 14, 2023 08:30 ET | Novan, Inc.
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
2019 logo_150x35_jpg.jpg
Novan Moves Forward with Unified Corporate Branding
March 08, 2023 09:00 ET | Novan, Inc.
– Novan is a fully integrated pharmaceutical company with proven capabilities across drug development through to commercialization – – EPI Health adopts Novan corporate branding, creating unified...
2019 logo_150x35_jpg.jpg
Novan to Report Full Year 2021 Financial Results on February 22, 2022
February 15, 2022 09:00 ET | Novan, Inc.
DURHAM, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2021 financial results on Tuesday, February...
2019 logo_150x35_jpg.jpg
Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
November 02, 2021 08:30 ET | Novan, Inc.
– Mr. Johnson brings broad commercial expertise with over 30 years of leadership spanning dermatology marketing, sales, sales management, digital marketing and managed care –– Company received...
2019 logo_150x35_jpg.jpg
Novan Announces Inclusion in Russell Microcap® Index
June 24, 2021 08:05 ET | Novan, Inc.
DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that as part of the annual reconstitution of the Russell stock indexes, Novan...